Crossmark

Literature-based case analysis of serious adverse drug events associated with edoxaban

Published Online: 2025-06-07

Published Print: 2025-08

Authors

Luan, Xuanyu

Zhou, Dongyang

Zhang, Qingxia https://orcid.org/0000-0002-3843-8767
Funding

Funding for this research was provided by:

National Health Commission of the People's Republic of China (NIHAYS2326)

Chinese Pharmacological Society (ADR2024MS01⁃ADR2024MS27)

Chinese Pharmaceutical Society (CPA⁃Z05⁃ZC⁃2023⁃002)

National Key Research and Development Program of China (2020YFC2008305)
License Information

Text and Data Mining valid from 2025-06-07

Version of Record valid from 2025-06-07
More Information

Article History

Received: 23 March 2025

Accepted: 3 June 2025

First Online: 7 June 2025

Declarations

:

: The authors declare no competing interests.

Document is current